Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies

INTRODUCTION: Although synthetic and biologic disease-modifying antirheumatic drugs are available, many patients with rheumatoid arthritis have a difficult-to-control disease and need other treatment options. Repository corticotropin injection (RCI) may alleviate symptoms and exacerbations in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Peter A, Rapoport, Ronald J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808698/
https://www.ncbi.nlm.nih.gov/pubmed/29445306
http://dx.doi.org/10.2147/OARRR.S153307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808698/
https://www.ncbi.nlm.nih.gov/pubmed/29445306
http://dx.doi.org/10.2147/OARRR.S153307

Ejemplares similares